← FDA Drug Approvals (Drugs@FDA)

OXYTROL

NDA · New Drug Application · Sponsor: ALLERGAN · Approved 2003-02-26

Drug application

FDA Application #

NDA021351

Application type

New Drug Application

Brand name

OXYTROL

Generic name

OXYBUTYNIN

Active ingredients

OXYBUTYNIN

Dosage form

FILM, EXTENDED RELEASE

Route

TRANSDERMAL

Marketing status

Prescription

Sponsor

ALLERGAN

Manufacturer

Allergan, Inc.

First approval

2003-02-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown